A new highly efficient immunomagnetic cell depletion device used for purging of T-cells in bone marrow and leukapheresis samples.

被引：0
|
作者：
Schulte-Vels, C [1 ]
Kleine, HD [1 ]
Buthmann, U [1 ]
Freund, M [1 ]
机构：
[1] Univ Rostock, Dept Hematol & Oncol, Div Internal Med, D-18055 Rostock, Germany
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2685
引用
收藏
页码：651A / 651A
页数：1
相关论文
共 50 条
  • [21] PURGING METHODS IN AUTOLOGOUS (REMOVAL OF RESIDUAL MALIGNANT-CELLS) OR ALLOGENEIC (REMOVAL OF T-CELLS) BONE-MARROW TRANSPLANTATION - PILOT-STUDIES
    HERVE, P
    FLESCH, M
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1986, 28 (02): : 97 - 105
  • [22] Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction
    Mapara, MY
    Korner, IJ
    Hildebrandt, M
    Bargou, R
    Krahl, D
    Reichardt, P
    Dorken, B
    BLOOD, 1997, 89 (01) : 337 - 344
  • [23] DEPLETION OF T-CELLS FROM HUMAN-BONE MARROW WITH MONOCLONAL-ANTIBODY CT-2 AND COMPLEMENT
    TRIGG, ME
    BILLING, R
    SONDEL, PM
    DICKERMAN, JD
    ERICKSON, C
    FINLAY, JL
    BOZDECH, M
    HONG, R
    PADILLANASH, H
    TERASAKI, P
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1984, 3 (04): : 406 - 412
  • [24] DIFFERENTIAL EFFECT OF 4-HYDROPEROXYCYCLOPHOSPAMIDE AND ANTIMYELOID MONOCLONAL-ANTIBODIES ON T-CELLS AND NATURAL-KILLER-CELLS DURING BONE-MARROW PURGING
    ZHONG, RK
    DONNENBERG, AD
    RUBIN, J
    BALL, ED
    BLOOD, 1994, 83 (08) : 2345 - 2351
  • [25] T-CELL FUNCTION IN BONE-MARROW CHIMERAS - ABSENCE OF HOST-REACTIVE T-CELLS AND COOPERATION OF HELPER T-CELLS ACROSS ALLOGENEIC BARRIERS
    BOEHMER, HV
    SPRENT, J
    TRANSPLANTATION REVIEWS, 1976, 29 : 3 - 23
  • [26] BONE-MARROW TRANSPLANTATION FOR HEMATOPOIETIC NEOPLASIA - EVALUATION OF A NEW APPROACH TO T-CELL DEPLETION
    SPECK, B
    DAZZI, H
    GRATWOHL, A
    TICHELLI, A
    NISSEN, C
    BONE MARROW TRANSPLANTATION, 1989, 4 : 56 - 57
  • [27] QUANTITATION OF HUMAN-BONE MARROW T-CELLS AFTER INVITRO DEPLETION BY THE MONOCLONAL-ANTIBODY CAMPATH-1
    IRLE, C
    KAESTLI, M
    CHAPUIS, B
    JEANNET, M
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, 115 (43) : 1517 - 1518
  • [28] GRAFT-REJECTION AFTER TRANSPLANTATION OF T-CELL-DEPLETED BONE-MARROW - INVESTIGATIONS ON THE IMPACT OF T-CELLS, GVHR AND MARROW CELL DOSE
    GLASS, B
    UHAREK, L
    GASSMANN, W
    LOEFFLER, H
    MUELLERRUCHHOLTZ, W
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 721 - 721
  • [29] IMMUNOLOGICAL DEPLETION OF T-CELLS IN MARROW GRAFTS PRIOR TO ALLOGENIC BONE-MARROW TRANSPLANTATION - EFFECTIVENESS IN THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE
    CAHN, JY
    HERVE, P
    FLESCH, M
    PLOUVIER, E
    RACADOT, E
    MONTCUQUET, P
    NOIR, A
    PETERS, A
    FLORIS, RLD
    PRESSE MEDICALE, 1986, 15 (25): : 1204 - 1204
  • [30] RECOVERY OF ANTIGEN-INDUCED T-CELL PROLIFERATION WITH UNMODIFIED BONE-MARROW VERSUS BONE-MARROW WITH A FIXED LOW NUMBER OF T-CELLS
    DEGAST, GC
    GRATAMA, JW
    VERDONCK, LF
    ZWAAN, FE
    MUDDE, GC
    BONE MARROW TRANSPLANTATION, 1988, 3 : 140 - 140
12345